Covivio
GSEFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,276 | $1,020 | $1,068 | $967 |
| % Growth | 25.1% | -4.6% | 10.5% | – |
| Cost of Goods Sold | $299 | $193 | $308 | $262 |
| Gross Profit | $977 | $827 | $897 | $799 |
| % Margin | 76.6% | 81.1% | 83.9% | 82.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | -$50 | $6 | $14 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $502 | $2,678 | $121 | $119 |
| Operating Expenses | $502 | $2,628 | $127 | $133 |
| Operating Income | $475 | -$1,685 | $810 | $1,480 |
| % Margin | 37.3% | -165.3% | 75.8% | 153.1% |
| Other Income/Exp. Net | -$254 | -$425 | $476 | -$17 |
| Pre-Tax Income | $221 | -$2,110 | $1,286 | $1,463 |
| Tax Expense | $24 | -$207 | $138 | $169 |
| Net Income | $68 | -$1,419 | $621 | $924 |
| % Margin | 5.3% | -139.2% | 58.1% | 95.5% |
| EPS | 0.64 | -14.55 | 6.61 | 9.79 |
| % Growth | 104.4% | -320.1% | -32.5% | – |
| EPS Diluted | 0.64 | -14.55 | 6.57 | 9.73 |
| Weighted Avg Shares Out | 107 | 98 | 94 | 94 |
| Weighted Avg Shares Out Dil | 107 | 98 | 95 | 95 |
| Supplemental Information | – | – | – | – |
| Interest Income | $43 | $13 | $17 | $11 |
| Interest Expense | $330 | $287 | $158 | $160 |
| Depreciation & Amortization | $1,147 | $74 | $59 | $75 |
| EBITDA | $1,698 | $973 | $878 | $766 |
| % Margin | 133.1% | 95.4% | 82.1% | 79.3% |